ENDO 2024 Call for Abstracts

November 30, 2023

Taking place in person in Boston, MA, June 1-4, there is no better place to share your research than ENDO. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most. All accepted abstracts will also be published in a supplement to our Open Access publication, Journal of the Endocrine Society (JES) and assigned a DOI. Outstanding abstracts submitted by in-training fellows and new faculty are also eligible for abstract awards. Abstract submissions are now closed. Late-breaking abstracts will be accepted March 19 - April 10, 2024.


Abstract submitters can access the ENDO Presenter Portal for information on submissions.  Presenting authors on submitted abstracts will receive an email notification of their acceptance status in early-March.

  • Print receipts: Access your submission via the ENDO Presenter Portal to print a receipt for the $90 abstract handling fee and to print a confirmation of your submission.
  • Register for ENDO 2024: Remember, payment of the $90 abstract handling fee does not include registration for the annual meeting. Abstract presenters must register to present at the annual meeting and to have their abstract published in a supplement to our Open Access publication, Journal of the Endocrine Society (JES)There will be no options for virtual participation at ENDO 2024. The annual meeting will be fully in-person.
  • Review abstract presentation formats: ENDO 2024 will feature in-person posters, Rapid-Fire presentations, and Oral Abstract sessions. Learn more about presentation formats.

If you have any questions regarding your abstract, contact abstracts@endocrine.org.

ENDO 2024 Abstract Embargo Policy

Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO. Please visit the ENDO media resource page for more information.

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.